The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Neural Implants Market Projected To Become By 2030 Based On Its 2026 Valuation?
The neural implants market size has experienced rapid expansion in recent years. This market is projected to expand from $5.91 billion in 2025 to $6.53 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.4%. Historically, this growth has been fueled by factors such as the increasing occurrence of neurological conditions, a rise in the population of chronic pain sufferers, the growing acceptance of deep brain stimulation treatments, the proliferation of neurology specialty centers, and accumulating clinical evidence supporting neuromodulation techniques.
The neural implants market is anticipated to experience robust expansion over the coming years. It is projected to grow to $9.2 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period can be attributed to advancements in implantable neurotechnology, an increasing geriatric population affected by neurological conditions, a rising demand for personalized neurology treatments, the expansion of outpatient neurological procedures, and heightened investment in neurotechnology research. Prominent trends within the forecast period include the increasing uptake of neurostimulation therapies for chronic disorders, the growing utilization of implantable devices for movement disorders, the expanding clinical acceptance of brain-computer interface technologies, the broadening of neuromodulation applications beyond pain management, and the rising demand for long-term solutions in managing neurological disorders.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15618&type=smp
Which Market Drivers Are Supporting The Expansion Of The Neural Implants Market?
The increasing occurrence of neurological conditions is anticipated to fuel the expansion of the neural implants market in the future. A neurological disorder is defined as any condition affecting the nervous system, characterized by anatomical, biochemical, or electrical irregularities within the brain, spinal cord, or peripheral nerves. The rise in neurological disorders can be attributed to multiple factors, including an aging demographic, genetic vulnerabilities, and evolving diagnostic standards. Neural implants are utilized to manage and treat diverse neurological ailments by directly interacting with the nervous system to either restore or augment neural functions. Such implants offer a customized method, potentially boosting the effectiveness of therapy and reducing negative side effects, particularly for conditions like Parkinson’s disease, epilepsy, and spinal cord injuries. For example, in 2024, data from the Department of Health and Human Services – a US federal cabinet department dedicated to safeguarding American health and well-being via numerous initiatives – indicated that in 2023, over 6 million Americans were affected by Alzheimer’s disease. Projections suggest this figure will substantially climb annually with an aging populace, reaching 13 million by 2060. Consequently, the growing incidence of neurological disorders is propelling the expansion of the neural implants market.
What Segment Groups Are Identified Within The Neural Implants Market?
The neural implants market covered in this report is segmented –
1) By Product: F And B Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)
2) By Application: Chronic Pain, Parkinson’s Disease (PD), Epilepsy, Other Applications
3) By End-User: Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers
Subsegments:
1) By F And B Spinal Cord Stimulation (SCS): Traditional Spinal Cord Stimulation, High-Frequency Spinal Cord Stimulation, Burst Spinal Cord Stimulation
2) By Deep Brain Stimulation (DBS): Subthalamic Nucleus (Stn) Dbs, Globus Pallidus Internus (Gpi) Dbs, Ventral Intermediate Nucleus (Vim) Dbs
3) By Vagus Nerve Stimulation (VNS): Implantable Vagus Nerve Stimulators, Non-Invasive Vagus Nerve Stimulators
What Trends Are Advancing Progress In The Neural Implants Market?
Leading companies within the neural implant market are concentrating on developing innovative products, such as deep brain stimulation (DBS) devices, to address movement disorders like Parkinson’s disease and essential tremors, aiming to gain a competitive advantage. Deep Brain Stimulation (DBS) devices are medical implants that treat neurological disorders by delivering electrical impulses to specific brain regions. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and healthcare company, launched Liberta RC, which is the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, designed for individuals living with movement disorders. It boasts the fewest recharges among all FDA-approved DBS systems, needing only 10 recharge sessions per year for most users. This product is integrated with Abbott’s proprietary NeuroSphere virtual clinic, allowing customers to contact clinicians, confirm proper settings and functionality, and receive updated treatment settings remotely. The system employs a wireless charger that can be positioned over the product, enabling users to remain active while wearing it. The device also provides customers with helpful notifications and customized settings to ensure a personalized charging experience.
Which Companies Hold Significant Positions In The Neural Implants Market?
Major companies operating in the neural implants market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Nevro Corp., NeuroPace Inc., Axonics Modulation Technologies Inc., Saluda Medical, Nuvectra Corporation, Cerbomed GmbH, Inspire Medical Systems Inc., Synchron Inc., Blackrock Neurotech, Neuralink, BrainGate, Bioinduction Ltd, SetPoint Medical, CereGate, Gyrus ACMI, Aleva Neurotherapeutics
Read the full neural implants market report here:
https://www.thebusinessresearchcompany.com/report/neural-implants-global-market-report
How Is The Neural Implants Market Distributed Across Key Geographic Regions?
North America was the largest region in the neural implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neural implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Neural Implants Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15618&type=smp
Browse Through More Reports Similar to the Global Neural Implants Market 2026, By The Business Research Company
Implantable Neurostimulation Devices Market Report 2026
Smart Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-implants-global-market-report
Microelectronic Medical Implants Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model